Turkey - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Turkey Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases decreased by 6% year on year. At 256 Cases in 2019, the country was number 95 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases. India ranked the highest with 66,255 Cases in 2019, +13.6% compared to 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia witnessed the worst performance at -100% per year.
Loading...
Date | Units (Cases) |
---|---|
2019 | 256.00 |
2018 | 257.00 |
2017 | 252.00 |
2016 | 256.00 |
2015 | 304.00 |
Download all data from 2005 to 2019
How does Turkey rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
# | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
---|---|---|---|---|---|---|---|
1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
92 |
#92
Egypt
|
264 | 2019 | +85.9 % | +25.1 % | View data | |
95 |
#95
Turkey
|
256 | 2019 | -0.4 % | -6.0 % | View data | |
97 |
#97
Lithuania
|
246 | 2019 | -2.4 % | -2.5 % | View data |